William Benton Jones - 04 Dec 2025 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
SVP, Pharmaceutical Development
Signature
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
Issuer symbol
CRVS
Transactions as of
04 Dec 2025
Transactions value $
$0
Form type
4
Filing time
08 Dec 2025, 16:23:09 UTC
Previous filing
06 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jones William Benton SVP, Pharmaceutical Development C/O CORVUS PHARMACEUTICALS, INC., 901 GATEWAY BOULEVARD, THIRD FLOOR, SOUTH SAN FRANCISCO /s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D. 08 Dec 2025 0001664506

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Stock Option (Right to Buy) Award $0 +400K $0.00 400K 04 Dec 2025 Common Stock 400K $8.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from December 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Remarks:

SVP, Pharmaceutical Development